For Antimicrobial (Drug) Resistance Researchers

NIAID is funding and conducting research on many aspects of antimicrobial (drug) resistance, including basic research on how microbes develop resistance, development of new and faster diagnostics, and clinical trials designed to find new vaccines and treatments effective against drug-resistant microbes.

Through the information offered here, researchers can learn about the science being conducted at NIAID and by NIAID-funded researchers. Researchers seeking funding can access opportunities to further their own research, while NIAID and NIH grantees can find out about available resources outside of specific funding opportunities. Recent publications, active networks, and ways to connect with other researchers are also available.


An issue as complex as antimicrobial resistance requires a comprehensive approach that draws upon not only federal agencies and academic researchers, but also industry, healthcare providers, and individual citizens to advance basic and applied research as well as to support public health efforts.

To assist with antimicrobial resistance research, NIAID established the Antibacterial Resistance Leadership Group (ARLG) to help address the most important clinical questions in antibacterial resistance.



NIAID offers resources such as technology for licensing or collaboration, computer applications, and other tools and services developed in its labs to the general scientific community for the advancement of biomedical research.

Funding Opportunities

All currently open NIAID Requests for Applications (RFAs) and Program Announcements (PAs) can be found on the NIAID Funding Opportunities list

Recent Research Initiatives

Recent research initiatives focused exclusively or in part on antimicrobial resistance.

Content last reviewed on July 11, 2016